Top Abstract Purchase Related
Home
>
Node
>
Subnode

Drug and patient matching for safer oral contraception

Pattillo, R.A.

Drug Therapy 5(4): 105-112

1975

ISSN/ISBN: 0001-7094
PMID: 12334093
Document Number: 505243
Oral contraceptives are of 3 kinds: 1) pills containing a combination of estrogen-progestogen; 2) a pill cycle made up of daily doses of first estrogen, then progestogen; and 3) pills containing only progestogen. Prescription of a specific oral contraceptive should be made by matching the patient's premedication endocrine profile with expected side effects of each medication. A chart is given of side effects caused by: estrogen excess and deficiency and progesteron excess and deficiency. Adjustment of the estrogen/progestogen balance or dosage of the medication should correct the side effects.

Document emailed within 1 workday
Secure & encrypted payments

MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
Quereux, C.; Bory, J.P. 1998: Interaction médicamenteuse et contraception orale - Drug interaction and oral contraception Journees sur la Fertilite et l'Othogenie 26(2): 129-131
Cooney, G.F.; Alpern, J.B.; Narins, B.E.; Goetz, L.K.; Cavarocchi, N.C. 1989: Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug Clinical Transplants 1989: 324
Logan, R.F.; Kay, C.R. 1989: Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study International Journal of Epidemiology 18(1): 105-107
Logan, R.F.; Kay, C.R. 1989: Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study International Journal of Epidemiology 18(1): 105-107
Logan, R.F.; Kay, C.R. 1989: Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study International Journal of Epidemiology 18(1): 105-107
Ryder, N.B.; Westoff, C.F. 1966: Use of oral contraception in the United States, 1965. in only 5 years oral contraception has become a major means of regulating fertility Science 153(3741): 1199-1205
Lavarenne, J.; Paire, M. 1990: Interactions de la contraception orale. III, contraception orale et médicaments divers - Drug interactions with oral contraceptives la Lettre du Pharmacologue (Boulogne) 4(5): 138-140
Wenderlein, J.M. 2000: Proper education for the patient! Risk of thromboembolism with oral contraception MMW Fortschritte der Medizin 142(7): 38-39
Potts, M.; Smith, J.B. 1992: Contraception and safer sex Bailliere's Clinical Obstetrics and Gynaecology 6(1): 199-211
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5
Szapiro, N. 1994: Contraception orale par Moneva étude de cohorte potant sur près de 6000 femmes résultats du sous-groupe «Contraception orale chez la jeune femme» - Oral contraception with Moneva. Cohorte study among 6000 women. Results of the study «Oral contraception for young women» Comptes Rendus de Therapeutique et de Pharmacologie Clinique (120): 3-5